Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update 

Go back to Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update 
GALECTIN (NASDAQ: GALT) Delayed: 4.05 -0.09 (2.17%)
Previous Close $4.14    52 Week High $3.05 
Open $4.13    52 Week Low $0.49 
Day High $4.34    P/E N/A 
Day Low $4.04    EPS $-1.32 
Volume 515,590